KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Evolent Health (EVH) Leases (2019 - 2025)

Evolent Health has reported Leases over the past 7 years, most recently at $4.4 million for Q4 2025.

  • Quarterly results put Leases at $4.4 million for Q4 2025, down 28.71% from a year ago — trailing twelve months through Dec 2025 was $4.4 million (down 28.71% YoY), and the annual figure for FY2025 was $4.4 million, down 28.71%.
  • Leases for Q4 2025 was $4.4 million at Evolent Health, down from $4.8 million in the prior quarter.
  • Over the last five years, Leases for EVH hit a ceiling of $53.7 million in Q1 2021 and a floor of $4.4 million in Q4 2025.
  • Median Leases over the past 5 years was $22.4 million (2023), compared with a mean of $28.1 million.
  • Biggest five-year swings in Leases: rose 1.15% in 2022 and later plummeted 75.7% in 2024.
  • Evolent Health's Leases stood at $50.2 million in 2021, then decreased by 2.34% to $49.0 million in 2022, then plummeted by 75.56% to $12.0 million in 2023, then plummeted by 48.81% to $6.1 million in 2024, then decreased by 28.71% to $4.4 million in 2025.
  • The last three reported values for Leases were $4.4 million (Q4 2025), $4.8 million (Q3 2025), and $5.3 million (Q2 2025) per Business Quant data.